Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Karpinich NO"'
Autor:
Roboz GJ, Yee K, Verma A, Borthakur G, de la Fuente Burguera A, Sanz G, Mohammad HP, Kruger RG, Karpinich NO, Ferron-Brady G, Acusta A, Del Buono H, Collingwood T, Ballas M, Dhar A, Wei AH
Publikováno v:
Leukemia & lymphoma
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::e2923b92cf4577c43228ce6e5e3bac1e
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=15262
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=15262
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hilton JF; The Ottawa Hospital Cancer Centre, Ottawa, ON, Canada., Ott PA; Dana Farber Cancer Institute, Boston, MA, USA., Hansen AR; Princess Margaret Cancer Centre, Toronto, ON, Canada., Li Z; New York University, New York, NY, USA., Mathew M; Columbia University Irving Medical Center, New York, NY, USA., Messina CH; GSK, Collegeville, PA, USA., Dave V; GSK, Bengaluru, Karnataka, India., Ji X; GSK, Collegeville, PA, USA., Karpinich NO; GSK, Collegeville, PA, USA., Hirschfeld S; GSK, Collegeville, PA, USA., Ballas M; GSK, Collegeville, PA, USA., Zandberg DP; UPMC Hillman Cancer Center, 5150 Centre Avenue, Pittsburgh, PA, 15232, USA. zandbergdp@upmc.edu.
Publikováno v:
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2024 Feb 13; Vol. 73 (3), pp. 44. Date of Electronic Publication: 2024 Feb 13.
Autor:
Dawson MA; Department of Clinical Haematology, Peter MacCallum Cancer Centre, Royal Melbourne Hospital, Melbourne, Victoria, Australia.; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia., Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Huntly BJP; University of Cambridge, Cambridge, United Kingdom., Karadimitris A; Hugh and Josseline Langmuir Centre for Myeloma Research, Centre for Haematology, Department of Immunology and Inflammation, Imperial College London and Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom., Alegre A; Hospital Universitario de La Princesa and Quironsalud, Madrid, Spain., Chaidos A; Hugh and Josseline Langmuir Centre for Myeloma Research, Centre for Haematology, Department of Immunology and Inflammation, Imperial College London and Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom., Vogl DT; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Pollyea DA; University of Colorado School of Medicine, Aurora, Colorado., Davies FE; Perlmutter Cancer Center, NYU Langone Medical Center, New York, New York., Morgan GJ; Perlmutter Cancer Center, NYU Langone Medical Center, New York, New York., Glass JL; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, New York., Kamdar M; University of Colorado School of Medicine, Aurora, Colorado., Mateos MV; Hospital Universitario de Salamanca, IBSAL, CIBERONC, Salamanca, Spain., Tovar N; Hospital Clínic, University of Barcelona, Barcelona, Spain., Yeh P; Department of Clinical Haematology, Peter MacCallum Cancer Centre, Royal Melbourne Hospital, Melbourne, Victoria, Australia.; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia., Delgado RG; Hospital Virgen de la Victoria, Málaga, Spain., Basheer F; Addenbrooke's Hospital, Cambridge, United Kingdom., Marando L; University of Cambridge, Cambridge, United Kingdom., Gallipoli P; Addenbrooke's Hospital, Cambridge, United Kingdom., Wyce A; GSK, Collegeville, Pennsylvania., Krishnatry AS; GSK, Collegeville, Pennsylvania., Barbash O; GSK, Collegeville, Pennsylvania., Bakirtzi E; GSK, Collegeville, Pennsylvania., Ferron-Brady G; GSK, Collegeville, Pennsylvania., Karpinich NO; GSK, Collegeville, Pennsylvania., McCabe MT; GSK, Collegeville, Pennsylvania., Foley SW; GSK, Collegeville, Pennsylvania., Horner T; GSK, Collegeville, Pennsylvania., Dhar A; GSK, Collegeville, Pennsylvania., Kremer BE; GSK, Collegeville, Pennsylvania., Dickinson M; Department of Clinical Haematology, Peter MacCallum Cancer Centre, Royal Melbourne Hospital, Melbourne, Victoria, Australia.; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Feb 16; Vol. 29 (4), pp. 711-722.
Autor:
Wyce A; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA., Matteo JJ; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA., Foley SW; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA., Felitsky DJ; Target Sciences, GlaxoSmithKline, Upper Merion, PA, USA., Rajapurkar SR; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA., Zhang XP; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA., Musso MC; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA., Korenchuk S; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA., Karpinich NO; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA., Keenan KM; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA., Stern M; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA., Mathew LK; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA., McHugh CF; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA., McCabe MT; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA., Tummino PJ; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA.; Janssen Pharmaceuticals, Spring House, Montgomery, PA, USA., Kruger RG; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA., Carpenter C; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA., Barbash O; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA. olena.x.barbash@gsk.com.
Publikováno v:
Oncogenesis [Oncogenesis] 2018 Apr 20; Vol. 7 (4), pp. 35. Date of Electronic Publication: 2018 Apr 20.
Autor:
Karpinich NO; From the Department of Cell Biology and Physiology (N.O.K., K.M.C.) and Department of Genetics (K.M.C.), University of North Carolina at Chapel Hill., Caron KM; From the Department of Cell Biology and Physiology (N.O.K., K.M.C.) and Department of Genetics (K.M.C.), University of North Carolina at Chapel Hill. kathleen_caron@med.unc.edu.
Publikováno v:
Arteriosclerosis, thrombosis, and vascular biology [Arterioscler Thromb Vasc Biol] 2015 May; Vol. 35 (5), pp. 1147-55. Date of Electronic Publication: 2015 Mar 19.